A Genome-Wide Association Study in Psoriasis Patients Reveals Variants Associated with Response to Treatment with Interleukin-17A Pathway Inhibitors
This GWAS identified novel variants that could be utilized upon validation in larger populations as predictive markers regarding patient response to drugs targeting the IL-17A pathway.
Authors
- Themistoklis Giannoulis (ORCID: https://orcid.org/0000-0002-1842-5432)
- Efterpi Zafiriou (ORCID: https://orcid.org/0000-0002-6594-7292)
- Theologia Sarafidou
- Kalliopi Liadaki (ORCID: https://orcid.org/0000-0001-6268-3394)
- Kalliopi Gerogianni
- Dimitrios P. Bogdanos (ORCID: https://orcid.org/0000-0002-9697-7902)
- Dimitra Ioakeimidou
- Olga Kouvarou
Institutions
- University of Thessaly (GR)
Publication Details
- Journal
- Genes
- Published
- 2025-10-13
- DOI
- https://doi.org/10.3390/genes16101187
- Citations
- 1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- University of Thessaly